IBM, KPMG, Walmart, Merck Reveal Results of FDA Blockchain Drug Tracing Pilot
IBM, KPMG, Walmart, and Merck’s blockchain pilot in drug-tracing has successfully exceeded the US Food and Drug Administration’s (FDA) benchmarks. The pilot program aimed to encourage new technologies to be used in the pharmaceutical supply chain. Blockchain was used as a shared record movement of pharmaceutical drugs through the supply chain, which resulted in improved efficiency. Recalls were proven to be done in just seconds, rather than in days, as blockchain offers traceability.